Trial intelligence / Profile preview

Zanubrutinib plus intrathecal chemotherapy for prevention of central nervous system recurrence in high-risk diffuse large B-cell lymphoma

ChiCTR2300072657Phase 4Recruiting

Sponsor

Sir Run-Run Shaw Hospital

Start

Mar 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1